1.Clinical efficacy analysis of interventional treatment of iatrogenic massive vaginal bleeding
Shengdong QIN ; Chaodi LI ; Yuhong HOU ; Yanping ZHAO ; Su YAN ; Ruixia GUO ; Xinwei HAN ; Jianhao ZHANG
Journal of Practical Radiology 2024;40(1):103-106
		                        		
		                        			
		                        			Objective To investigate the clinical efficacy and value of interventional treatment of iatrogenic massive vaginal bleed-ing.Methods Retrospective analysis was performed on 35 patients with postoperative vaginal massive hemorrhage in obstetrics and gynecology who were admitted.Abdominal aorta and bilateral internal iliac arteries angiography and embolization of abnormal vessels were performed under digital subtraction angiography(DS A),and relevant clinical data were recorded and analyzed.Results After interventional treatment,the vaginal bleeding of 33 patients basically stopped within 3 days,and the average interventional operation time was(57.5±17.2)min.The hemoglobin value,hematocrit and blood pressure decreased and the heart rate increased significantly before and after interventional embolization in obstetrics and gynecology,with statistical significance(P<0.05).There were no sig-nificant changes in hemoglobin value and hematocrit between the completion of interventional embolization and 72 hours after interventional embolization(P>0.05).The increase of blood pressure and the decrease of heart rate were statistically significant(P<0.05).Two patients with cesarean section had poor hemostatic effect after interventional embolization,and the bleeding stopped after exploratory laparotomy and hysterectomy.Conclusion Interventional treatment has the advantages of small trauma,simple operation,signifi-cant curative effect,few adverse reactions,and rapid recovery.It plays an important role and clinical value in the diagnosis and treat-ment of iatrogenic vaginal bleeding.
		                        		
		                        		
		                        		
		                        	
2.Relationship between symptomatic knee osteoarthritis and frailty among elderly people in China
Liyi ZHANG ; Quan ZHANG ; Qiang LIU ; Yaohui ZHAO ; Jianhao LIN
Chinese Journal of Geriatrics 2023;42(9):1117-1122
		                        		
		                        			
		                        			Objective:To analysis the relationship between symptomatic knee osteoarthritis and frailty in older Chinese adults.Methods:In this retrospective study, follow-up data between 2011 and 2015 from the China Health and Retirement Longitudinal Study(CHARLS)were analyzed.Participates over 60 years old were divided into a frailty group, a pre-frailty group, and a normal group, according to the frailty phenotype.Cross-sectional analysis was conducted to examine the relationship between frailty and symptomatic knee osteoarthritis, and the role of symptomatic knee osteoarthritis in the progression of frailty in normal elderly people was further analyzed using a retrospective cohort.Results:In 2011, 5.9% of the elderly were frail and 15.1% of the elderly suffered knee pain.Univariate and multivariate regression analysis indicated that knee pain was a risk factor for frailty( OR: 1.91, 95% CI: 1.37-2.61, P<0.01).After a 4 year-follow-up, 41.7% of the normal elderly participants progressed to the frail or pre-frail state.Multivariate regression analysis suggested that knee pain was a risk factor for normal elderly people to enter the frail or pre-frail state( OR: 1.57, 95% CI: 1.00-2.45, P<0.05). Conclusions:Knee pain is one of the important risk factors for the development of frailty in the elderly.Normal elderly people with knee pain are at an increased risk of frailty or pre-frailty in later years.
		                        		
		                        		
		                        		
		                        	
3.Research progress in the pathogenesis of extramedullary disease in multiple myeloma
Journal of International Oncology 2023;50(1):55-59
		                        		
		                        			
		                        			Multiple myeloma (MM) lesions are mostly localized in the marrow. Extramedullary disease in multiple myeloma (MM-EMD) is defined as malignant plasma cell infiltration away from the bone marrow or adjacent soft tissue, may occur at the initial diagnosis or during the consultation. MM-EMD may be found at initial diagnosis or during the treatment. MM-EMD has high invasiveness and poor prognosis, with clinical behavior distinct from marrow-restricted myeloma. However, its pathogenesis has not been elucidated. In general, the obstructed homing of myeloma cells, enhanced invasiveness, the degradation of extracellular matrix, and increased angiogenesis capacity may be involved in the occurrence of MM-EMD. Tumor genetic abnormalities and changes in the bone marrow microenvironment play important roles in the above pathogenesis.
		                        		
		                        		
		                        		
		                        	
4.Development of radiolabeled tetramer that targeting fibroblast activation protein and theranostic research in tumor xenografts
Liang ZHAO ; Jianhao CHEN ; Yizhen PANG ; Jianyang FANG ; Zhide GUO ; Hua WU ; Long SUN ; Qin LIN ; Haojun CHEN
Chinese Journal of Nuclear Medicine and Molecular Imaging 2023;43(6):343-348
		                        		
		                        			
		                        			Objective:To develop a tetramer probe targeting fibroblast activation protein (FAP), named 1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetraacetic acid (DOTA)-4P(FAP inhibitor (FAPI)) 4, evaluate its biodistribution and PET image in FAP-positive-tumor bearing nude mice, and explore its feasibility as a novel radio-regent for treatment of FAP-positive tumor. Methods:FAP tetramer probe was constructed on the FAPI-46 motif with four mini-polyethylene glycol (PEG)(PEG 3) spacers between the four FAPI motifs, denoted as 4P(FAPI) 4. DOTA was used as the chelator for radiolabeling with 68Ga and 177Lu. The FAP binding characteristics were test by in vitro cell competitive binding experiment. Small-animal PET, in vivo biodistribution, and radionuclide targeting therapy were performed in HT-1080-FAP tumor bearing nude mice ( n=39). Independent-sample t test was performed to analyze tumor uptake data, and two-factor repeated measures analysis of variance was utilized to compare tumor volume data in radioactive isotope therapy. Results:Cell experiment showed that FAPI-tetramer and FAPI-monomer had similar half maximal inhibitory concentration values (3.29 and 2.15 nmol/L). 68Ga/ 177Lu radiolabeled FAPI-tetramer had better tumor uptake and retention than FAPI-monomer in small-animal PET and in vivo biodistribution experiment, with the tumor uptake for 177Lu-DOTA-4P(FAPI) 4 and 177Lu-FAPI-46 at 48 h of (18.72±1.32) vs (2.72±1.20) percentage activity of injection dose per gram of tissue (%ID/g) ( t=15.55, P<0.001). 177Lu-DOTA-4P(FAPI) 4 group showed best anti-tumor efficacy compared with 177Lu-FAPI-46 and control group in radionuclide targeting therapy. On the 2nd day after the start of treatment, the tumor volume in the tetramer treatment group was significantly smaller than that in the control group (mean difference 67.19 mm 3, P=0.049); on the 14th day after the start of treatment, the tumor volume in the tetramer treatment group was significantly smaller than that in the monomer treatment group (mean difference 414.33 mm 3, P=0.005). Conclusion:FAPI-tetramer can improve tumor uptake and retention ability compared with FAPI-46, and 177Lu-DOTA-4P(FAPI) 4 can be a promising radio-agent for FAP-positive tumor therapy.
		                        		
		                        		
		                        		
		                        	
5.Morphological analysis of meibomian glands in patients with meibomian gland cyst under in vivo confocal microscope
Jianhao CAI ; Cangeng XU ; Lingling ZHOU ; Zifeng ZHAO ; Zeyi LI ; Yuansheng ZHOU
Chinese Journal of Experimental Ophthalmology 2021;39(2):139-143
		                        		
		                        			
		                        			Objective:To analyze the morphological changes and features of meibomian gland in patients with meibomian gland cyst under in vivo confocal microscope (IVCM). Methods:A cross-sectional study was performed.A total of 34 patients (34 eyes) with meibomian gland cysts and 18 control subjects (18 eyes) in the outpatient department without meibomian gland cysts treated in Shantou International Eye Center from September 2018 to April 2019 were included into the meibomian gland cyst group and control group accordingly.All the subjects underwent routine ophthalmologic examination and IVCM examination.IVCM test indicators included the opening area of meibomian gland, the longest diameter and the shortest diameter of meibomian gland opening, the morphology of glandular tube and acinus adjacent to the meibomian gland opening.The measurement indexes of the meibomian gland cyst group and the control group were compared and analyzed.This study followed the Declaration of Helsinki and was approved by the Ethics Committee of Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong (No.EC20171103[6]-P01). Written informed consent was obtained from each patient before examination.Results:The opening of the meibomian glands of the 34 subjects in the meibomian gland cyst group were all enlarged irregularly with smooth boundaries, and emboli in the openings were observed in 70.59% (24/34) of patients.The longest diameter, the shortest diameter and the area of meibomian gland openings were (148.12±70.16)μm, (114.77±52.38)μm and 9 239.11(5 506.96, 24 111.36)μm 2 in the meibomian gland cyst group, respectively, while (59.35±16.78)μm, (41.98±11.77)μm and 2 094.19 (1 432.28, 2 945.65)μm 2 in the control group, respectively.Compared with the control group, the longest diameter and shortest diameter in the meibomian cyst group were longer, and the area of meibomian gland openings in the meibomian cyst group was larger, and the differences were statistically significant (all at P<0.01). Adjacent to the opening, there was cystic dilation of glandular tube containing accumulated secretion of different characteristics detected in the 61.76% (21/34) of patients in the meibomian gland cyst group, and the dilated glandular tubes were with flat edges.The boundaries between the dilated glandular tubes and surrounding acini were clear. Conclusions:In vivo confocal microscope can detect the morphological changes of meibomian glands in patients with meibomian gland cyst, including enlarged opening with embolus, cystic dilation of glandular tube with clear boundary and accumulated secretion.
		                        		
		                        		
		                        		
		                        	
6.Effects of dietary nutrients on arsenic toxicity
Chinese Journal of Endemiology 2021;40(1):70-74
		                        		
		                        			
		                        			Environmental arsenic exposure is a worldwide public health problem. Long-term exposure to inorganic arsenic is closely related to diseases such as cardiovascular disease, diabetes and malignant tumors. Different dietary structure and intake of certain specific nutrients may have important effects on the pathogenic effect of arsenic. This article summarizes the effects of dietary nutrients on arsenic toxicity, providing reference for the follow-up arsenic toxicity research and reducing the risk of arsenic-related diseases through nutritional intervention.
		                        		
		                        		
		                        		
		                        	
7.Preliminary study on the application of abdominal aortic balloon occlusion in the treatment of cesarean scar pregnancy
Jianhao ZHANG ; Hongjian DUAN ; Yanping ZHAO ; Yuhong HOU ; Xinwei HAN ; Na LIU ; Ke HU ; Zhipeng FENG ; Ruixia GUO
Chinese Journal of Obstetrics and Gynecology 2020;55(8):516-520
		                        		
		                        			
		                        			Objective:To explore the clinical value by analyzing the application of abdominal aortic balloon occlusion in the uterine curettage treatment for patients with cesarean scar pregnancy (CSP).Methods:Totally 42 CSP patients in the first Affiliated Hospital of Zhengzhou University were analyzed retrospectively, 21 cases in the observation group, placing the balloon catheter to the abdominal aorta under the renal artery under the digital substraction angiography(DSA), conducting curettage under hysteroscopy or uterine laparoscopy immediately, and making intermittent blockage in abdominal aorta blood flow during the surgery;21 patients in the control group, conducting uterine artery embolization (UAE) before operation, conducting curettage under hysteroscopy or uterine laparoscopy after 1-3 days. The fluoroscopy time under DSA, body surface radiation dose, intraoperative blood loss, operation time, incidence of postoperative adverse reactions, hospitalization time and follow-up menstruation were comparatively analyzed.Results:All patients operated and retained the uterus successfully. In the control group, all 21 patients had different degrees of fever, pain and other symptoms after UAE. In the observation group and control group, the fluoroscopy time and body surface radiation dose under DSA respectively were (7.4±1.4) s, (5.4±1.1) mGy and (1 142.8±315.5) s, (1 442.0±300.0) mGy (both P<0.01);the average amount of intraoperative blood loss were (22±15), (19±14) ml ( P>0.05), the time of uterine curettage were (37±20), (42±19) minutes ( P>0.05);hospitalization time were (5.0±0.9), (7.7±1.3) days ( P<0.01). The follow-up period was more than 3 months, no adverse reactions were observed in the observation group; 4 cases of menstrual reduction and 1 case of intrauterine adhesions were found in the control group. Conclusion:Abdominal aortic balloon occlusion and UAE could effectively reduce intraoperative bleeding in uterine curettage for patients with CSP; abdominal aortic balloon occlusion has significant reduction of the X-ray dose, shorter hospitalization time, and fewer adverse events comparing to UAE.
		                        		
		                        		
		                        		
		                        	
8.Survey of Chinese orthopedists' cognition on the Chinese Osteoarthritis Guideline (2018 Edition)
Dan XING ; Bin WANG ; Chi ZHOU ; Ting YUAN ; Weili FU ; Wei LI ; Jiaguo ZHAO ; Yuankun XU ; Yu ZHAO ; Yang YANG ; Nan YANG ; Yaolong CHEN ; Jianhao LIN
Chinese Journal of Orthopaedics 2020;40(9):577-583
		                        		
		                        			
		                        			Objective:To investigate the orthopedists' cognition on Chinese Osteoarthritis Guideline (2018 Edition).Methods:Questionnaire about Chinese Osteoarthritis Guideline (2018 Edition) was developed and sent to orthopedists via an invitation link to fill out after authorization from Chinese Osteoarthritis Association. The content of the questionnaire included the basic personal information of the physician, the awareness rate of the guidelines, the evaluation of the guidelines, and its application effects. The survey duration was from September 2019 to December 2019. Multivariate logistic regression and linear regression analysis were performed for the guideline awareness rate and comprehensive score, respectively.Results:A total of 628 physicians completed the questionnaire, of which 623 of 628 (99.2%) were available. About 72.4% of the orthopedists knew the guideline. The awareness rate was statistically related to the education of the physicians ( P<0.05). Respondents' overall score for the guideline was 8.39 with methodological score 8.28. A total of 41.2% of orthopedists thought that the guideline was very good compared with the European and American guidelines, and the clinical problem coverage rate was 78.6%. There is a statistically significant difference in the appraisal of the recommendations ( χ2=138.9, P<0.05) . More than 40% of orthopedists believed that the guidelines were of great help to orthopedists and patients, and that the guide could be promoted to the primary hospitals. Conclusion:After one year publication of Chinese Osteoarthritis Guideline (2018 Edition), most orthopedists have understood the present guideline and applied recommendations in clinical practice. However, the guideline need to be further promoted and disseminated in the future.
		                        		
		                        		
		                        		
		                        	
9.3D stem cells-laden cytoniches for cartilage defect in rabbit
Dan XING ; Wei LIU ; Yu ZHAO ; Hui LI ; Jianhao LIN
Chinese Journal of Orthopaedics 2020;40(14):945-952
		                        		
		                        			
		                        			Objective:To culture UC-MSCs with 3D TableTrix TM stem cell microcarrier and further evaluate the effects on cartilage defect of knee joint in rabbit model. Methods:UC-MSCs were cultured in 3D TableTrix TM system for 7 d. The cell viability was evaluated and characteristics of UC-MSCs were identified. The safety of 3D 3D TableTrix TM system was further evaluated by subcutaneous implantation in nude mice. Twelve New Zealand white rabbits were randomly divided into control group and experimental group. The experimental group was placed in 3D TableTrix TM with UC-MSCs. At 3 and 6 months after the operation, the samples were taken for general observation, HE, toluidine blue, Masson staining for comparative observation. According to the International Cartilage Repair Society (ICRs), general evaluation and histological score was evaluated quantitatively. Results:The UC-MSCs survived well in 3D TableTrix TM system. There was no dead cell with dead/live staining after 7 d culture. UC-MSCs proliferated in 3D TableTrix TM system. After digestion, the UC-MSCs were identified to maintain the characteristics of MSCs. After 28 d of subcutaneous implantation in nude mice, agglomerations were formed and covered with fibrous membrane. HE staining showed that the 3D TableTrix TM scaffold structure was complete and neovascularized. In vivo study, 3D TableTrix TM was used to fill the cartilage defect. At 3 and 6 months after operation, the effects on cartilage repair in the experimental group was better than that in the control group. The overall score of ICRS (3 month, 8.50±0.58 vs 4.50±0.58; 6 months, 11.25±0.96 vs 8.75±0.50, P<0.05) and histological score of the experimental group were higher than that of the control group (3 month, 11.00±2.16 vs 5.25±0.50; 6 month 17.00±0.82 vs 11.25±0.96, P<0.05). Conclusions:3D TableTrix TM microcarrier provides an ideal microenvironment for stem cell culture, and that can be used in the treatment of cartilage defects.
		                        		
		                        		
		                        		
		                        	
10.Influence of ticagrelor on levels of serum high sensitive C reactive protein and plasma homocysteine in patients with acute coronary syndrome/
Dayu WANG ; Shanjun ZHAO ; Jiayong LIANG ; Jianhao LI ; Wenzhu ZHANG ; Jun CHEN
Chinese Journal of cardiovascular Rehabilitation Medicine 2019;28(1):72-75
		                        		
		                        			
		                        			Objective :To explore influence of ticagrelor on levels of serum high sensitive C reactive protein (hsCRP) and plasma homocysteine (Hcy) in patients with acute coronary syndrome (ACS).Methods :A total of 135 ACS pa‐ tients hospitalized in our department from Jan 2016 to Feb 2017 were selected .Based on routine treatment ,Patients were randomly and equally divided into routine group ,clopidogrel group and ticagrelor group (based on routine treatment respectively received clopidogrel or ticagrelor ) for four weeks .Levels of serum hsCRP and plasma Hcy were measured and compared among all groups before and after treatment .Results :Compared with before treat‐ment ,after four‐week treatment , there were significant reductions in levels of serum hsCRP and plasma Hcy in three groups (P<0. 05 or <0.01).Compared with routine group and clopidogrel group after four‐week treatment , there were significant reductions in levels of serum hsCRP [ (12.95 ± 1.99) mg/L , (8. 56 ± 1. 24) mg/L vs.(4. 47 ± 1. 92) mg/L] and plasma Hcy [ (13.48 ± 2.12) μmol/L , (9.55 ± 0. 94) μmol/L vs.(6. 61 ± 1. 15) μmol/L] in ticagrelor group ( P<0.05 or <0.01).Conclusion :Ticagrelor can significantly reduce levels of serum hsCRP and plasma Hcy while effective antiplatelet therapy ,then significantly inhibit inflammatory response ,improve vascular endothelial function ,contribute to stabilizing atherosclerotic plaques ,improve prognosis in ACS patients .
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail